SUPPLEMENTARY INFORMATION
RAPID COMMUNICATION
Rapid, efficient and eco-friendly procedure for the synthesis of quinoxalines under solvent-free conditions using sulfated polyborate as a recyclable catalyst
KRISHNA S INDALKAR, CHETAN K KHATRI and GANESH U CHATURBHUJ*
Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Mumbai, Maharashtra 400 019, India
Email: [email protected] *For Correspondence
Table of Contents
Page
1. Experimental S2
1.1. Materials and methods
S2
1.2. Preparation of sulfated polyborate catalyst S2
1.3. General procedure for the synthesis of quinoxaline derivatives
S2
2. Spectral data of synthesized compounds S4
3. Copies of 1HNMR and 13C NMR spectra of synthesized compounds S5
4. References S11
S1
1. Experimental
1.1 Materials and methods:
Melting points of all the compounds were recorded by AnalabThermoCal melting point
apparatus in the open capillary tube and are uncorrected. The FTIR spectra (KBr) were
recorded on Shimadzu FTIRAffinity-1 Fourier Transform Infrared spectrophotometer. 1H
NMR spectra were recorded on MR400 Agilent Technology NMR spectrometer using
tetramethylsilane (TMS) as an internal standard and DMSO-d6/CDCl3 as solvent. X-ray
diffractograms (XRD) were recorded on Rigakuminiflex X-ray Diffractometer. The SEM-
EDAX characterization was performed on a JEOL JSM-638DLA scanning electron
microscope equipped with energy dispersive X-ray spectrometer. The potentiometric analysis
was performed on ElicoLI 120 pH meter. Chemicals and solvents used were of LR grade and
purchased from SD fine, Avra Synthesis and Spectrochem and used without purification. The
purity determination of the starting materials and reaction monitoring was accomplished by
thin-layer chromatography (TLC) on Merck silica gel G F254 plates. All the products are
known compounds and were identified by 1H NMR spectroscopy.
1.2 Preparation of sulfated polyborate catalyst:
Boric acid was heated in a petri dish at 200 °C for 4h to convert it to the polyboric acid;
resultant glassy solid was then ground into fine powder. Polyboric acid powder (5 g) was
suspended in chloroform (20 ml) in 250 ml round bottom flask, then chlorosulfonic acid (4.23
ml) was added dropwise over a period of 30 minutes at room temperature. The mixture was
further stirred for 120 min. The reaction was quenched by adding ethanol (10 ml). Residual
HCl gas was flushed with nitrogen, the solid was filtered, washed several times with
chloroform. Finally, solid sulfated polyborate was dried at 100 °C in hot air oven till constant
weight.The catalyst was characterized by various analytical techniques such as
potentiometric analysis, Fourier transform infrared spectroscopy (FTIR), X-ray
diffraction (XRD), and scanning electron microscopy (SEM) energy dispersive X-ray
spectroscopy (EDAX).
1.3General procedure for the synthesis of quinoxaline derivatives
S2
To a mixture of substituted o-phenylenediamines derivative (2.0 mmol) and 1,2-
diketone / α-hydroxy ketone (2.0 mmol) was added sulfated polyborate (10 wt %).
The reaction mixture was stirred at 100 °C in an oil bath. The reaction was monitored
by thin layer chromatography (TLC). After completion of the reaction, the mixture
was cooled to room temperature and quenched by water. The resultant product was
filtered/extracted with EtOAc to get the product. Crude products either
recrystallizedfrom ethanol or purified by column chromatography using silica as
stationary phase and EtOAc: pet. ether solvent system. The products obtained were
known compounds and were identified by melting point and 1H NMR spectroscopy.
The spectral data were compared with the literature values.
S3
2. Spectral data of synthesized compounds:
1. 2,3-diphenylquinoxaline (Table 3, entry 1):1,2
White solid, 1H NMR (400 MHz, CDCl3): δ 8.18- 8.16 (m, 2H), 7.78- 7.76 (m, 2H), 7.52-7.50 (m, 4H), 7.34-7.31 (m, 6H).13C NMR (101MHz, CDCl3): δ 153.44, 141.20, 139.05, 129.92, 129.80, 129.18, 128.77, 128.24.
2. 5-methyl-2,3-diphenylquinoxaline (Table 3, entry 2): 2,3
White solid, 1H NMR (400 MHz, CDCl3): δ 8.00 (d, J= 8 Hz, 1H), 7.66-7.51(m, 6H), 7.34- 7.25 (m, 6H), 2.85 (s, 3H).13C NMR (101MHz, CDCl3): δ 152.78, 151.72, 141.11, 140.35, 139.37, 139.32, 137.58, 130.10, 129.76, 129.64, 128.64, 128.25, 128.06, 126.91, 17.10.
3. 6-chloro-2,3-diphenylquinoxaline (Table 3, entry 5):2,3
White solid, 1H NMR (400 MHz, CDCl3): δ 8.16 (s, 1H), 8.10 (d, J= 8 Hz, 1H), 7.70 (d, J = 8 Hz1H), 7.51-7.49 (m, 4H), 7.37-7.31(m, 6H).13C NMR (101MHz, CDCl3): δ 154.25, 153.58, 141.44, 139.68, 138.68, 138.61, 135.62, 130.92, 130.39, 129.80, 129.75, 129.07, 128.98, 128.28, 128.04.
4. 6-nitro-2,3-diphenylquinoxaline (Table 3, entry 6):1
Light yellow solid, 1H NMR (400 MHz, CDCl3): δ 9.07 (s, 1H), 8.53 (d, J = 8 Hz, 1H), 8.29 (d, J = 8 Hz, 1H), 7.57-7.54 (m, 4H), 7.42- 7.35 (m, 6H).
5. 2,3-dimethylquinoxaline (Table 3, entry 7):3,4
Light yellow solid, 1H NMR (400 MHz, CDCl3): δ 7.97-7.94(m, 2H), 7.65-7.63 (m, 2H), 2.71 (s, 6H).13C NMR (101MHz, CDCl3): δ 153.42, 141.04, 128.77, 128.27, 23.16.
6. Quinoxaline (Table 3, entry 13)5
Brown Solid, 1H NMR (400 MHz, CDCl3): δ 8.85 (s, 2H), 8.12-8.10 (m, 2H), 7.79-7.77(m, 2H).
7. 6-chloroquinoxaline (Table 3, entry 17):6
Brown Solid, 1H NMR (400 MHz, CDCl3):δ 8.84 (d, J = 4.4 Hz, 2H), 8.10 (s, 1H), 8.04 (d, J = 8 Hz1H), 7.72 (d, J = 8 Hz, 1H).
8. 6-butylquinoxaline (Table 3, entry 18):
Brown liquid, 1H NMR (400 MHz, CDCl3):δ 8.78 (d, J = 8 Hz, 2H), 8.00 (d, J = 12 Hz, 1H), 7.87(s, 1H), 7.62(d, J = 8 Hz, 1H), 2.89(t, J = 8 Hz, 2H), 1.75-1.68 (m, 2H), 1.43-1.37 (m, 2H), 0.94 (t, J = 8 Hz,3H).
S4
13C NMR (101MHz, CDCl3): δ 145.47, 144.80, 144.06, 143.10, 141.67, 131.73, 129.00, 127.60, 35.67, 33.06, 22.25, 13.87.
3. Copies of 1HNMR and 13C NMR spectra of synthesized compounds:
1. 2,3-diphenylquinoxaline (Table 3, entry 1):
13C NMR (101 MHz, CDCl3)
S5
2. 5-methyl-2,3-diphenylquinoxaline (Table 3, entry 2):
13C NMR (101 MHz, CDCl3)
S6
3. 6-chloro-2,3-diphenylquinoxaline (Table 3, entry 5):
13C NMR (101 MHz, CDCl3)
S7
4. 6-nitro-2,3-diphenylquinoxaline (Table 3, entry 6):
5. 2,3-dimethylquinoxaline (Table 3, entry 7):
S8
13C NMR (101 MHz, CDCl3)
6. Quinoxaline (Table 3, entry 13):
S9
7. 6-chloroquinoxaline (Table 3, entry 17):
8. 6-butylquinoxaline (Table 3, entry 18)
S10
13C NMR (101 MHz, CDCl3)
5. References
S11
1. Kadam H K, Khan S, Kunkalkar R A and Tilve S G 2013 Graphite catalyzed green synthesis of
quinoxalines Tetrahedron Lett. 54 1003
2. Zhang X Z, Wang J X, Sun Y J and Zhan H W 2010 Synthesis of quinoxaline derivatives catalyzed
by PEG-400 Chin. Chem. Lett. 21 395
3. Go A, Lee G, Kim J, Bae S, Lee B M and Kim B H 2015 One-pot synthesis of quinoxalines from
reductive coupling of 2-nitroanilines and 1,2-diketones using indium Tetrahedron 71 1215
4. Paul S and Basu B 2011 Synthesis of libraries of quinoxalines through eco-friendly tandem
oxidation–condensation or condensation reactions Tetrahedron Lett. 52 6597
5. Zhou W, Taboonpong p, Aboo A, Zhang L, Jiang J and Xiao J 2016 A convenient procedure for the
oxidative dehydrogenation of n-heterocycles catalyzed by FeCl2/DMSO Synlett 27 1806
6. Chambers R, Parsons M, Sandford G, Skinner C, Atherton M and Moilliet J 1999 Elemental
fluorine. Part 10.1 Selective fluorination of pyridine,quinoline and quinoxaline derivatives with
fluorine–iodine mixtures J. Chem. Soc. Perkin Trans. 1 803
S12